Ivim Health Semaglutide: Hybrid In-Person and Telehealth Model

Published May 25, 2026Updated May 27, 2026Last reviewed May 25, 2026

For the broader cluster context, see the compounded semaglutide provider comparison hub.

Author: HealthRX Editorial Team Medically reviewed by: Dr. Mark Halpern, MD (Internal Medicine, Obesity Medicine) Last clinical review: May 2026

Compounded semaglutide is not FDA-approved. This article is patient education and does not replace consultation with a licensed clinician.

Rachel, 41, lives in Boise and spent three months on a telehealth-only semaglutide program before switching to Ivim Health last January. "I was having GI issues at 1.0 mg, and my telehealth provider kept telling me to wait it out over chat," she told us. "My first in-person visit at the Ivim clinic took twenty minutes. The NP palpated my abdomen, ordered a metabolic panel on-site, and adjusted my dose that afternoon. It felt like actual medicine again." She pays $299 a month, about $80 more than her previous provider. She says it's worth it. Whether that math works for you depends entirely on where you live.

That geographic caveat is the whole story with Ivim Health. It's one of the only compounded semaglutide providers in 2026 that runs physical clinics alongside its telehealth program. If you're in one of their footprint markets, that hybrid model is a genuine differentiator. If you're not, you're paying a slight premium for a telehealth experience that several competitors match or beat on price.

This review covers Ivim's 2026 program structure, pricing, pharmacy sourcing, clinical model, and how it stacks up. It sits inside the broader best compounded semaglutide telehealth providers comparison, which is part of the compounded semaglutide pillar guide.

What Ivim Health Actually Is

Ivim operates a network of physical clinics concentrated in the Mountain West (Utah, Colorado, Idaho, Wyoming) and the Southeast (Tennessee, Georgia, Florida), plus a telehealth-only program covering roughly 40 states. If you live near a clinic, you can choose in-person, hybrid, or telehealth-only care. Everyone else gets the telehealth track.

The compounded semaglutide is dispensed through 503A pharmacy partners. Post-shortage (the FDA resolved the semaglutide shortage in February 2025), their 2026 formulations are personalized preparations that satisfy the 503A clinical-need standard, meaning each prescription is patient-specific rather than batch-produced.

Pricing runs $259 to $339 per month. The spread depends on your plan structure, which protocol your clinician prescribes, and whether adjunct medications are included. Telehealth-only basic plans sit at the lower end. In-person visits, more frequent follow-ups, or adjunct prescriptions push you toward the higher end.

The In-Person Advantage (and Its Limits)

Here's the thing about most compounded semaglutide providers in 2026: they're screens. Asynchronous chat, maybe a scheduled video call. That works fine for straightforward cases. It works less well when something goes sideways.

Ivim's hybrid structure creates a few practical differences for patients in footprint markets:

An in-person initial consultation with a physical exam, which is technically the standard of care for any new medication initiation. Most telehealth competitors skip this by necessity.

In-person follow-ups when clinically indicated, particularly useful for patients with complicating medical histories or side effects that need hands-on evaluation.

On-site lab draws. No scheduling a separate Quest or Labcorp visit. No waiting for results to route through a third-party portal.

The obvious limitation: this only matters if you're near a clinic. A patient in Portland or Philadelphia is using Ivim as a pure telehealth provider, and at that point the comparison against pure-telehealth competitors is apples to apples, except Ivim tends to cost more.

My honest take: for patients who live within a reasonable drive of an Ivim clinic and want the reassurance of face-to-face care, this is probably the most medically conventional option in the compounded semaglutide space. For everyone else, the value proposition weakens considerably.

How the Pricing Compares

Putting Ivim's $259 to $339 range in context against the broader market:

HealthRX: $179.99 to $279.99 flat-rate
Hims (annual commitment): $199 effective
ShedRx (6-month plan): $249
Ivim Health: $259 to $339
Mochi Health (all-in): ~$279
Eden: $296
Henry Meds: $297

Ivim lands in the middle of the pack. Not the cheapest, not the most expensive. For in-person patients, the premium over HealthRX or Hims buys you something tangible (physical exams, on-site labs). For telehealth-only patients, the extra $60 to $80 per month over the lowest-cost competitors buys you a more clinician-involved model, but you could get similar clinical density from Mochi or Lavender Sky at comparable or lower price points.

Pharmacy Sourcing and Regulatory Standing

Ivim uses 503A pharmacy partners. They'll name the specific pharmacy after enrollment if you ask (and you should ask). The clinical model produces individualized prescriptions consistent with the 503A patient-specific compounding standard.

Two things worth flagging on the regulatory front:

Ivim has not been named as a defendant in the active Novo Nordisk civil litigation alleging "inauthentic API" sourcing, based on a review of public court records in early 2026. They also haven't received an FDA warning letter. That's a clean profile in a category where at least one major competitor (Hims) has caught warning letters on marketing claims.

Ivim Health is LegitScript-certified, verifiable on the LegitScript registry. This matters for legitimacy signaling, though it's not a substitute for doing your own diligence on the specific pharmacy filling your prescription.

Two Different Clinical Experiences

The clinical model really does split into two distinct tracks depending on geography.

In footprint markets: Your initial visit is typically in-person with a physical exam. Follow-ups can be in-person or video, your choice (or your clinician's recommendation). Labs are drawn at the clinic. You're seeing Ivim's in-house clinical staff, which means continuity of care is built in.

Telehealth-only: Initial visit by video. Assigned clinician, scheduled follow-ups, dose adjustments based on clinical situation. Baseline labs are required and arranged through partner labs. Structurally, this looks a lot like other clinician-network providers.

Across both tracks, Ivim runs a more involved clinical model than asynchronous-first competitors. Expect scheduled touchpoints. The clinician drives the cadence, not you. Some patients find that reassuring; others find it inconvenient. It's like the difference between a scheduled dental cleaning and an on-demand teeth whitening app. Both serve a function. Different patients want different things.

Questions to Ask Before You Commit

Skip the marketing site. Call or message and ask these directly:

Is there an Ivim clinic near me? If so, what's the cost difference between in-person and telehealth-only plans?

What will I pay at the highest dose I might reach during titration? (The $259 starting figure can creep upward.)

Which 503A pharmacy fills my prescription, and is it in my state?

What baseline labs do you require, and who orders them?

What's the visit cadence in months one through three?

If I have side effects at a given dose, what's the adjustment protocol?

These aren't trick questions. Any legitimate provider should answer them without hesitation.

How Ivim Stacks Up Against HealthRX

This comparison hinges almost entirely on geography.

If you're in a footprint market: Ivim's in-person option is a real differentiator. HealthRX doesn't have physical clinics. You'll pay more ($259 to $339 versus $179.99 to $279.99), and whether the in-person component justifies that premium is a personal call. For patients with complex medical histories, comorbidities, or anxiety about managing injectable medications without hands-on support, it probably does.

If you're outside footprint markets: You're comparing two telehealth providers. HealthRX's flat-rate pricing is more transparent. HealthRX is LegitScript-certified. Ivim's telehealth model is a bit more clinician-driven. The choice comes down to whether you value predictable pricing (HealthRX) or a slightly more structured clinical relationship (Ivim).

Both providers use 503A pharmacy partners and have clean regulatory profiles as of early 2026.

Ivim vs. Mochi Health and Lavender Sky

Patients drawn to clinician-heavy models tend to compare these three. The structural differences are real.

Ivim is the only one with physical clinics. That's the headline. Mochi operates a clinician-network model in roughly 45 states. Lavender Sky runs a single-practice structure in about 35 states. Neither offers in-person visits.

On price, Ivim ($259 to $339) sits between Mochi ($129 to $279) and Lavender Sky ($299 to $399). Mochi can bill insurance for the visit component in some configurations, which can meaningfully change the out-of-pocket math.

For patients outside Ivim's footprint, the three providers differentiate mainly on price, state coverage, and how tightly you want to be connected to a specific clinician. Mochi's lower floor is attractive for cost-conscious patients. Lavender Sky's single-practice model appeals to patients who want a named provider relationship. Ivim's telehealth track falls in between.

The Boring Truth About Hybrid Models

Ivim Health is a well-run, LegitScript-certified provider with a genuine in-person component that distinguishes it from almost everything else in the compounded semaglutide market. That matters. Physical exams matter. On-site labs matter. Seeing the same clinician face-to-face matters, especially for a medication class where dose titration and GI side effects are common enough that the STEP-1 trial (Wilding et al., NEJM 2021) reported GI adverse events in 74.2% of the semaglutide group.

But the geographic constraint is real. If you don't live near a clinic in Utah, Colorado, Idaho, Wyoming, Tennessee, Georgia, or Florida, you're paying Ivim prices for a telehealth experience that several competitors deliver at lower cost. That's not a knock on Ivim's quality. It's just math.

For patients in footprint markets who value in-person care, Ivim is arguably the most medically conventional option available in compounded semaglutide right now. For everyone else, compare carefully.

Frequently Asked Questions

Does Ivim Health have physical clinics? Yes. Ivim operates clinics in the Mountain West (Utah, Colorado, Idaho, Wyoming) and the Southeast (Tennessee, Georgia, Florida). The specific clinic list is available on their website. Patients outside these markets use the telehealth-only program.

How much does Ivim Health semaglutide cost? $259 to $339 per month, depending on plan type, protocol, and whether adjunct medications are included. Telehealth-only basic plans are at the lower end; in-person or more clinically involved plans are at the higher end.

Is Ivim Health LegitScript-certified? Yes. Ivim Health's certification is verifiable on the LegitScript registry.

What pharmacy does Ivim Health use? Ivim works with 503A pharmacy partners. They'll disclose the specific pharmacy after enrollment. Prescriptions are individualized, consistent with 503A patient-specific compounding requirements.

Can I use Ivim Health if I don't live near a clinic? Yes. The telehealth-only program covers approximately 40 states. You'll have video consultations and labs arranged through partner facilities, but you won't have access to in-person visits.

Has Ivim Health received any FDA warning letters? No. As of early 2026, Ivim has not received an FDA warning letter and has not been named in the Novo Nordisk civil litigation regarding API sourcing.

How does Ivim Health compare to HealthRX? HealthRX is less expensive ($179.99 to $279.99), LegitScript-certified, and operates as pure telehealth with flat-rate pricing. Ivim's advantage is the in-person option for patients in footprint markets. For telehealth-only patients, HealthRX offers more pricing transparency at a lower cost.

Not FDA-approved. HealthRX is not a medical practice. Information on this site is for educational purposes and is not a substitute for individualized medical advice. Treatment decisions are made between you and a licensed clinician. Compounded semaglutide is dispensed by state-licensed 503A pharmacies under individual prescriptions for clinically documented patient-specific need. Pricing and program terms for Ivim Health are based on public information available in early 2026 and are subject to change. References: SUSTAIN program; STEP-1 (Wilding et al., NEJM 2021); STEP-3 (Wadden et al., JAMA 2021); STEP-4 (Rubino et al., JAMA 2021); SELECT (Lincoff et al., NEJM 2023); FDA Drug Shortage status update, February 2025.